Multiscale within-host modelling of SARS-CoV-2 infection reveals benefits and risks of early Remdesivir treatment

Add to your list(s) Download to your calendar using vCal

• Farzad Fatehi Chenar (University of York)
• Tuesday 07 July 2020, 15:00-15:30
• Seminar Room 2, Newton Institute.

If you have a question about this talk, please contact INI IT.

This talk has been canceled/deleted

The SARS CoV-2 outbreak has infected over ten million, and killed over 500,000, individuals worldwide, making the development of antiviral treatments against this virus a priority. Recent studies have identified Remdesivir as an effective antiviral treatment option for COVID -19. I will present a new stochastic agent based model for the intracellular dynamics of a SARS -CoV-2 infection that includes details on all essential steps of a viral life cycle, from viral entry to virion release. Using this model, I evaluate the effect of Remdesivir on the production of new virions. In a next step, I propose an intercellular model to study the viral dynamics within the body of an infected patient. The intercellular model is fitted to data recording the progress of viral load in 12 patients with COVID -19, showing how differing strengths of immune response can explain the variety of infection spans seen in patients. Coupling the intra and intercellular models allows for a comparative analysis of Remdesivir therapy for patients with different types of immune response.

This talk is part of the Isaac Newton Institute Seminar Series series.

This talk is included in these lists:

This talk is not included in any other list

Note that ex-directory lists are not shown.